Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AGTR1 | P30556 | 4/20 | 0.32 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.31 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.31 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.31 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.31 |
| ▸ | AGTR2 | P50052 | 1/20 | 0.30 |
| ▸ | CMKLR1 | Q99788 | 1/20 | 0.30 |
| ▸ | GSK3B | P49841 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4554039 | 0.94 | AGTR1 (0.36) | AGTR1AGTR2CMKLR1 | |
| SCHEMBL4553134 | 0.92 | ROCK2 (0.32) | ROCK2 | |
| SCHEMBL840643 | 0.78 | AGTR1 (0.37) | AGTR1AGTR2 | |
| SCHEMBL840644 | 0.77 | AGTR1 (0.35) | AGTR1AGTR2 | |
| SCHEMBL8315967 | 0.74 | AGTR1 (0.40) | AGTR1 | |
| SCHEMBL14544727 | 0.73 | AGTR1 (0.41) | AGTR1AGTR2CMKLR1 | |
| SCHEMBL4553631 | 0.72 | MMP8 (0.41) | — | |
| SCHEMBL4554384 | 0.72 | PDCD1 (0.30) | — | |
| SCHEMBL9709552 | 0.71 | IAPP (0.40) | AGTR1AGTR2 | |
| SCHEMBL2971001 | 0.71 | AGTR1 (0.51) | AGTR1AGTR2KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2132187-A2 | DUAL-ACTING ANTIHYPERTENSIVE AGENTS | Theravance, Inc. (US) | 2009-12-16 | — | — | EP | disclosed |
| WO-2008097459-A2 | DUAL-ACTING ANTIHYPERTENSIVE AGENTS | THERAVANCE, INC. (US) | 2008-08-14 | — | — | WO | disclosed |